THE CLINICAL SIGNIFICANCE OF INTERLEUKIN-4 IN SYSTEMIC SCLERODERMA. (2024). Spectrum Journal of Innovation, Reforms and Development, 27, 51-58. https://sjird.journalspark.org/index.php/sjird/article/view/1033